Human parainfluenza 2 & 4: Clinical and genetic epidemiology in the UK, 2013-2017, reveals distinct disease features and co-circulating genomic subtypes
Related Experiment Video
Updated: Sep 20, 2025

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
Akhil Chellapuri1, Matthew Smitheman1, Joseph G Chappell1,2
1School of Life Sciences, University of Nottingham, Nottingham, UK.
Background:
Human Parainfluenza viruses (HPIV) comprise of four members of the genetically distinct genera of Respirovirus (HPIV1&3) and Orthorubulavirus (HPIV2&4), causing significant upper and lower respiratory tract infections worldwide, particularly in children. However, despite frequent molecular diagnosis, they are frequently considered collectively or with HPIV4 overlooked entirely. We therefore investigated clinical and viral epidemiological distinctions of the relatively less prevalent Orthorubulaviruses HPIV2&4 at a regional UK hospital across four autumn/winter epidemic seasons.
Methods:
A retrospective audit of clinical features of all HPIV2 or HPIV4 RT-PCR-positive patients, diagnosed between 1st September 2013 and 12th April 2017 was undertaken, alongside sequencing of viral genome fragments in a representative subset of samples.
Results:
Infection was observed across all age groups, but predominantly in children under nine and adults over 40, with almost twice as many HPIV4 as HPIV2 cases. Fever, abnormal haematology, elevated C-reactive protein and hospital admission were more frequently seen in HPIV2 than HPIV4 infection. Each of the four seasonal peaks of either HPIV2, HPIV4 or both, closely matched that of RSV, occurring in November and December and preceding that of Influenza A. A subset of viruses were partially sequenced, indicating co-circulation of multiple subtypes of both HPIV2&4, but with little variation between each epidemic season or from limited global reference sequences.
Conclusions:
Despite being closest known genetic relatives, our data indicates a potential difference in associated disease between HPIV2 and HPIV4, with more hospitalisation seen in HPIV2 mono-infected individuals, but a greater overall number of HPIV4 cases.
Insights
Human Parainfluenza viruses (HPIV) 2 and 4 cause respiratory infections, with HPIV4 being more common but HPIV2 leading to more hospitalizations. This study differentiates their clinical and epidemiological features.
Area of Science:
- Virology
- Epidemiology
- Clinical Medicine
Background:
- Human Parainfluenza viruses (HPIV) cause significant respiratory infections globally, particularly in children.
- HPIV are classified into Respirovirus (HPIV1&3) and Orthorubulavirus (HPIV2&4) genera.
- HPIV2 and HPIV4 are often overlooked despite frequent molecular diagnosis.
Purpose of the Study:
- To investigate the clinical and epidemiological distinctions between Human Parainfluenza virus 2 (HPIV2) and Human Parainfluenza virus 4 (HPIV4).
- To analyze HPIV2 and HPIV4 infections across four autumn/winter seasons in a UK hospital setting.
Main Methods:
- Retrospective audit of clinical features for HPIV2 or HPIV4 RT-PCR-positive patients.
- Patient data collected between September 2013 and April 2017.
- Partial viral genome sequencing for a subset of samples.
Main Results:
- Infections occurred across all age groups, predominantly in children under nine and adults over 40.
- HPIV4 cases were nearly twice as common as HPIV2 cases.
- HPIV2 infections were associated with more frequent fever, abnormal hematology, elevated C-reactive protein, and hospital admission compared to HPIV4.
Conclusions:
- Despite genetic relatedness, HPIV2 and HPIV4 exhibit distinct disease associations.
- HPIV2 mono-infections were linked to higher hospitalization rates.
- HPIV4 infections occurred more frequently overall, indicating a greater public health impact in terms of case numbers.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Viral Recombination
Viral Mutations
Leaky Scanning

